Facebook
Twitter
LinkedIn
Forward
Obesity pharmacotherapy often is solely equated as therapeutic use of anti-obesity medications (AOMs). In this session, two important factors in obesity pharmacotherapy will be discussed.
|
This talk will review key features of obesity pathogenesis related to genetics, the brain, and energetics.
|
Poor responders to common medical weight loss treatments is a challenging situation for clinicians.
|
Obesity is one of the leading causes of the development of type 2 diabetes mellitus.
|
Is the intersection of Childhood Obesity and pediatric sleep problems merely confined to a discussion of poor sleep habits leading to weight gain?
|
Obesity is one of the leading causes of preventable death. Obesity-related increases metabolic and cardiovascular risk occur at a lower body mass index in Asian adults.
|
Nonviolent communication (NVC) developed by Dr.
|
This webinar will review current trends in the management of pediatric obesity.
|
In this webinar Lori Wenz, NP-C, BC-ADM will discuss the role of bariatric surgery in the treatment of diabetes.
|
Sarcopenic obesity presents numerous risks to health and quality of life.
|